Cargando…

Soluble Urokinase Receptor and Mortality in Kidney Transplant Recipients

Main problem: Soluble urokinase plasminogen activator receptor (suPAR) is an immunological risk factor for kidney disease and a prognostic marker for cardiovascular events. Methods: We measured serum suPAR levels in a total of 1,023 kidney transplant recipients either before (cohort 1, n = 474) or a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morath, Christian, Hayek, Salim S., Döhler, Bernd, Nusshag, Christian, Sommerer, Claudia, Zeier, Martin, Reiser, Jochen, Süsal, Caner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Health Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842271/ https://www.ncbi.nlm.nih.gov/pubmed/35185364 http://dx.doi.org/10.3389/ti.2021.10071

Ejemplares similares

ABO-Incompatible Kidney Transplantation
por: Morath, Christian, et al.
Publicado: (2017)

Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy—Results of a Prospective Single-Center Trial
por: Benning, Louise, et al.
Publicado: (2023)

Prospective Cohort Study of Soluble Urokinase Plasminogen Activation Receptor and Cardiovascular Events in Patients With CKD
por: Sommerer, Claudia, et al.
Publicado: (2023)

Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography
por: Sommerer, Claudia, et al.
Publicado: (2019)

Clinical Relevance of HLA Antibody Monitoring after Kidney Transplantation
por: Morath, Christian, et al.
Publicado: (2014)

Clinical Relevance of HLA Antibodies in Kidney Transplantation: Recent Data from the Heidelberg Transplant Center and the Collaborative Transplant Study
por: Süsal, Caner, et al.
Publicado: (2017)

Living Donor Kidney Transplantation in Patients With Donor-Specific HLA Antibodies After Desensitization With Immunoadsorption
por: Kälble, Florian, et al.
Publicado: (2021)

No Increase in Colon Cancer Risk Following Induction with Neu5Gc-Bearing Rabbit Anti-T Cell IgG (ATG) in Recipients of Kidney Transplants
por: Soulillou, Jean-Paul, et al.
Publicado: (2018)

Hemophagocytic lymphohistiocytosis in an adult kidney transplant recipient successfully treated by plasmapheresis: A case report and review of the literature
por: Nusshag, Christian, et al.
Publicado: (2017)

Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients
por: Benning, Louise, et al.
Publicado: (2022)

Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study
por: Nusshag, Christian, et al.
Publicado: (2019)

Rare Malignant Indications for Liver Transplantation: A Collaborative Transplant Study Report
por: Houben, Philipp, et al.
Publicado: (2021)

Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acid
por: Benning, Louise, et al.
Publicado: (2022)

Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus
por: Dande, Ranadheer R., et al.
Publicado: (2017)

Higher CD19+CD25(+) Bregs are independently associated with better graft function in renal transplant recipients
por: Ibrahim, Eman H., et al.
Publicado: (2021)

Issues of Acute Kidney Injury Staging and Management in Sepsis and Critical Illness: A Narrative Review
por: Nusshag, Christian, et al.
Publicado: (2017)

Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
por: Rovina, Nikoletta, et al.
Publicado: (2020)

The Differential Influence of Cold Ischemia Time on Outcome After Liver Transplantation for Different Indications—Who Is at Risk? A Collaborative Transplant Study Report
por: Lozanovski, Vladimir J., et al.
Publicado: (2020)

Can PIRCHE-II Matching Outmatch Traditional HLA Matching?
por: Unterrainer, Christian, et al.
Publicado: (2021)

Relationship of transitional regulatory B and regulatory T cells and immunosuppressive drug doses in stable renal transplant recipients
por: Ibrahim, Eman H, et al.
Publicado: (2021)

Hearing Impairments as an Overlooked Condition in Kidney Transplant Recipients
por: Simsir, Melis, et al.
Publicado: (2022)

Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation
por: Morath, Christian, et al.
Publicado: (2020)

Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2
por: Speer, Claudius, et al.
Publicado: (2021)

Excess Mortality in Kidney and Kidney-Pancreas Transplant Recipients in the COVID-19 Pandemic in Portugal—A Cohort Study
por: Coimbra, Miguel T., et al.
Publicado: (2023)

Living Donor Kidney Transplant in Recipients With Glomerulonephritis: Donor Recipient Biologic Relationship and Allograft Outcomes
por: El-Rifai, Rasha, et al.
Publicado: (2023)

A Kidney Transplant Recipient on Prophylactic Eculizumab Presenting With Myalgia
por: Shivakumar, Oshini, et al.
Publicado: (2022)

Split liver transplantation: Current developments
por: Hackl, Christina, et al.
Publicado: (2018)

Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High‐Sensitivity C‐Reactive Protein
por: Hayek, Salim S., et al.
Publicado: (2018)

Obesity is Associated With Delayed Graft Function in Kidney Transplant Recipients: A Paired Kidney Analysis
por: Shi, Bree, et al.
Publicado: (2023)

Kidneys From Elderly Deceased Donors—Is 70 the New 60?
por: Echterdiek, Fabian, et al.
Publicado: (2019)

Longitudinal Humoral Responses after COVID-19 Vaccination in Peritoneal and Hemodialysis Patients over Twelve Weeks
por: Speer, Claudius, et al.
Publicado: (2021)

Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients
por: Benning, Louise, et al.
Publicado: (2022)

Impact of Size Matching Based on Donor-Recipient Height on Kidney Transplant Outcomes
por: Tandukar, Srijan, et al.
Publicado: (2022)

Combined Donor-Recipient Obesity and the Risk of Graft Loss After Kidney Transplantation
por: Jarrar, Faisal, et al.
Publicado: (2022)

Predictors and Adverse Outcomes of Acute Kidney Injury in Hospitalized Renal Transplant Recipients
por: Hod, Tammy, et al.
Publicado: (2023)

The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial
por: Sommerer, Claudia, et al.
Publicado: (2014)

Impaired Neutralizing Antibody Activity against B.1.617.2 (Delta) after Anti-SARS-CoV-2 Vaccination in Patients Receiving Anti-CD20 Therapy
por: Töllner, Maximilian, et al.
Publicado: (2022)

Abatacept Rescue Therapy in Kidney Transplant Recipients: A Case Series of Five Patients
por: Uro-Coste, Charlotte, et al.
Publicado: (2022)

Telehealth Experience Among Liver and Kidney Transplant Recipients: A Mixed Methods Study
por: Ko, Dami, et al.
Publicado: (2023)

Neutralizing antibody activity against the B.1.617.2 (delta) variant 8 months after two-dose vaccination with BNT162b2 in health care workers
por: Benning, Louise, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_46cjdcej8lrbf1qcj5dpak8t2o